Boston Scientific Corporation BSX

43.92 (0.76) (1.70%) as of 25 Sep
Market cap
$64.7B
P/E
17.7×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
84.15 316.00 29.21 13.38 0.00 61.57 102.24 54.06 70.89 48.65
P/S ratio
3.54 3.83 4.97 5.86 5.14 5.08 5.19 5.90 7.85 7.03
P/FCF ratio
35.57 31.29 6,100.57 45.53 44.52 45.43 69.28 46.90 49.69 38.59
P/Operating CF
43.94 50.64 2,568.66 90.93 75.68 126.40 81.56 87.82 90.27 103.49
P/B ratio
4.41 4.94 5.59 4.53 3.32 3.63 3.75 4.30 5.97 5.77
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
4.17 4.43 5.67 6.77 5.89 5.68 5.82 6.48 8.47 7.50
EV/EBITDA
78.28 31.18 37.00 47.93 36.99 25.39 25.33 25.65 33.28 29.97
EV/Operating CF
29.60 28.10 179.72 39.60 38.69 36.13 48.38 36.87 41.27 33.22
EV/FCF
41.91 36.19 6,964.32 52.62 51.00 50.80 77.71 51.49 53.60 41.18
Quick Ratio
0.47 0.31 0.33 0.42 0.89 0.87 0.76 0.63 0.46 0.90
Current Ratio
0.90 0.68 0.76 0.97 1.82 1.48 1.51 1.32 1.08 1.62
Net Debt/EBITDA
4.15 2.54 2.84 3.72 4.70 2.68 2.75 2.29 2.43 1.88
Debt/Assets
30.31% 29.49% 33.60% 32.74% 29.71% 28.13% 27.52% 25.91% 27.28% 26.19%
Debt/Equity
0.81 0.80 0.81 0.72 0.60 0.55 0.51 0.47 0.49 0.47
Asset Turnover
0.46 0.49 0.49 0.42 0.32 0.38 0.39 0.42 0.45 0.48
Operating CF/Net income
3.41 13.71 0.19 0.39 (13.11) 1.90 2.38 1.59 1.85 1.56
Capex/Depreciation
(0.42) (0.38) (0.33) (0.41) (0.22) (0.37) (0.45) (0.57) (0.48) (0.62)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
5.32% 1.51% 21.24% 41.59% (0.79%) 6.17% 3.75% 8.46% 8.92% 12.47%
ROA
1.92% 0.56% 8.35% 18.23% (0.37%) 3.13% 1.98% 4.64% 4.97% 6.98%
ROIC
2.32% 6.46% 6.02% 4.01% (0.22%) 3.15% 4.02% 5.27% 5.04% 6.65%
Return on Tangible Assets
27.07% (77.04%) 318.29% 245.82% (2.26%) 22.93% 14.58% 35.36% 48.57% 39.21%
Average Days of Receivables
64.07 62.45 59.75 62.15 56.37 54.59 56.70 57.11 55.75 53.20
Research and Development Expense of Revenue
10.97% 11.02% 11.33% 10.94% 11.53% 10.13% 10.43% 9.93% 9.64% 10.22%
Selling, General and Administrative Expense of Revenue
37.90% 37.16% 37.05% 37.32% 38.66% 37.08% 36.01% 36.77% 35.93% 34.54%
Intangible Assets out of Total Assets
0.69 0.67 0.68 0.59 0.52 0.56 0.58 0.58 0.60 0.58
Share Based Compensation of Revenue
1.38% 1.40% 1.43% 1.46% 1.71% 1.63% 1.73% 1.64% 1.59% 1.49%
Graham Net Nets
(0.27) (0.24) (0.17) (0.19) (0.17) (0.15) (0.14) (0.11) (0.08) (0.07)
Graham Number
5.39 3.03 13.12 27.54 0.00 13.47 11.15 17.99 20.59 27.00
Earnings Yield
1.19% 0.32% 3.42% 7.47% (0.34%) 1.62% 0.98% 1.85% 1.41% 2.06%
Free Cash Flow Yield
2.81% 3.20% 0.02% 2.20% 2.25% 2.20% 1.44% 2.13% 2.01% 2.59%
Revenue per Share
6.18 6.60 7.11 7.71 7.00 8.36 8.87 9.80 11.38 13.56
Operating CF per Share
0.87 1.04 0.22 1.32 1.06 1.31 1.07 1.72 2.33 3.06
Capex per Share
(0.26) (0.23) (0.22) (0.33) (0.26) (0.38) (0.40) (0.49) (0.54) (0.59)
Free Cash Flow per Share
0.62 0.81 0.01 0.99 0.81 0.94 0.66 1.23 1.80 2.47
Cash per Share
0.14 0.14 0.11 0.16 1.22 1.35 0.65 0.60 0.28 1.33
Shareholders Equity per Share
4.96 5.12 6.32 9.97 10.82 11.69 12.28 13.44 14.95 16.53
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
4.96 5.12 6.32 9.97 10.82 11.69 12.28 13.44 14.95 16.53
Free Cash Flow
835.00 1,107.00 8.00 1,382.00 1,144.00 1,330.00 950.00 1,792.00 2,645.00 3,658.00
Working Capital
(348.00) (1,832.00) (1,257.00) (167.00) 3,013.00 2,043.00 1,957.00 1,581.00 521.00 3,355.00
Capital Expenditures
(347.00) (319.00) (302.00) (454.00) (364.00) (540.00) (576.00) (711.00) (790.00) (876.00)
Net Current Asset Value
(8,124.00) (8,208.00) (8,270.00) (11,989.00) (8,757.00) (9,290.00) (9,136.00) (9,092.00) (10,472.00) (10,407.00)
EV/EBIT
78.28 31.18 37.00 47.93 0.00 56.39 44.82 39.38 54.42 41.70
Capex to Sales
0.04 0.04 0.03 0.04 0.04 0.05 0.05 0.05 0.05 0.04
Net Profit Margin
4.14% 1.15% 17.01% 43.78% (1.16%) 8.29% 5.06% 11.03% 11.06% 14.44%
Price to Operating Income
66.45 26.95 32.41 41.48 0.00 50.43 39.96 35.87 50.45 39.08
Other line items
Depreciation/Fixed assets
0.51 0.50 0.52 0.54 0.79 0.65 0.52 0.44 0.50 0.35
Cash ROIC
(3.61%) (2.11%) (9.24%) (1.01%) (2.20%) (1.38%) (3.35%) (1.21%) 0.43% 1.31%
Accounts Receivable Turnover
6.11 5.99 6.23 6.25 5.90 7.19 6.77 6.78 7.00 7.32
Accounts Payable Turnover
7.39 5.31 6.40 6.99 6.57 5.68 4.78 4.82 5.53 5.91
Inventory Turnover
2.46 2.55 2.51 2.27 2.37 2.51 2.28 2.00 1.99 2.16
Average Days of Payables
67.31 74.60 45.28 63.49 54.04 78.09 79.53 79.13 66.65 67.12
Days of Inventory on Hand
143.80 151.74 151.29 184.96 142.31 158.35 172.26 208.67 195.10 172.67
Average Receivables
1,373.50 1,510.00 1,578.00 1,718.00 1,679.50 1,654.50 1,874.00 2,099.00 2,393.00 2,742.00
Average Payables
328.00 488.50 439.50 445.50 527.50 653.50 828.00 902.00 951.00 1,052.00
Average Inventory
985.50 1,016.50 1,122.00 1,372.50 1,465.00 1,480.50 1,738.50 2,175.50 2,647.00 2,876.50
Average Assets
18,114.50 18,569.00 20,020.50 25,782.00 30,671.00 31,503.00 32,349.00 33,802.50 37,265.50 41,534.00
Average Common Equity
6,526.50 6,872.00 7,868.00 11,301.00 14,602.00 15,975.00 17,098.50 18,551.50 20,766.00 23,237.00

Fold the line items

Columns are period end dates